Cannon Global Investment Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-28,000	Closed	-$51.2K	–	37
2024 Q1	$51.2K	Buy	+28,000	New	+$51.2K	0.14%	60